T1	intervention 66 77	anastrozole
T2	No-of-participants 499 503	3864
T3	No-of-participants 583 587	2980
T4	eligibility 588 618	postmenopausal women with DCIS
T6	outcome-Measure 668 697	Adherence to trial medication
T7	outcome 801 810	adherence
T5	control 638 647	tamoxifen
T8	control 544 551	placebo
T9	intervention-value 835 840	65.7%
T10	control-value 858 863	65.9%
T11	outcome 1108 1140	In the DCIS study, adherence was
T12	intervention-value 1161 1166	67.5%
T13	control-value 1186 1191	65.8%
T14	adverse-effect 1227 1238	Hot flashes
